Last reviewed · How we verify
Infuvite Adult (BIOTIN)
At a glance
| Generic name | BIOTIN |
|---|---|
| Sponsor | Pfizer |
| Drug class | Vitamin C [EPC] |
| Target | Insulin-degrading enzyme |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
| First approval | 1953 |
Approved indications
- Biotin deficiency disease
Common side effects
- Gastrointestinal disturbances
- Allergic sensitizations
- Gastrointestinal intolerance
- Nausea
- Diarrhea
- Constipation
- Anorexia
Key clinical trials
- Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment (NA)
- Mechanisms Accounting for Unexplained Anemia in the Elderly (PHASE1)
- Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies (PHASE1)
- Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion (PHASE1)
- Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling (EARLY_PHASE1)
- Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML (PHASE1,PHASE2)
- Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young Adults (PHASE1)
- Study Evaluating the Effects of Dietary Supplement on Hair Thickness and Hair Strength in Individuals With Self-Perceived Thinning Hair (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |